+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunohistochemistry Market Forecast to 2028 - COVID-19 Impact & Global Analysis by Application (Diagnostics, and Drug Testing); Product (Antibodies, Equipment, Reagents, and Kits); End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), & Geography

  • PDF Icon

    Report

  • 259 Pages
  • September 2021
  • Region: Global
  • The Insight Partners
  • ID: 4858419

Immunohistochemistry Market is expected to reach US$ 3,585.31 million by 2028

The immunohistochemistry market is expected to reach US$ 3,585.31 million by 2028 from US$ 2,171.61 million in 2021; it is estimated to register a CAGR of 7.4% from 2021 to 2028. Rising incidence of chronic and infectious diseases, increasing geriatric population, and rising R&D investments by biotechnology and biopharmaceutical companies are the key factors driving the market. However, the limitations associated with immunohistochemistry are hindering the market growth.





Immunohistochemistry (IHC) refers to an important application of monoclonal and polyclonal antibodies for tissue determination and distribution of antigens of a particular disease. It is majorly used to detect several infectious disorders such as dengue, hepatitis, and AIDS. Immunohistochemistry helps diagnose chronic medical conditions like obesity, cancer, diabetes, heart disease, and stroke.

According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), 37.6 million people across the globe had HIV in 2020. 35.9 million were adults, and 1.7 million were children (< 15 years old). An estimated 1.5 million individuals worldwide acquired HIV in 2020. According to the HIV and AIDS organization (AVERT), in 2018, 1.1 million US residents were infected with HIV, whereas APAC registered 5.2 million HIV-infected population. According to the European CDC, ~2 million people in Europe were infected with HIV in 2018.

Diabetes is prevailing at a high rate in the geriatric population worldwide. The prevalence of diabetes is more in overweight and obese people. As per data published by the Centers for Disease Control and Prevention (CDC) in 2017, ~30.3 million people, representing 94% of the population of the US, were diabetic. Among these, ~23.1 million people were diagnosed with diabetes, while ~7.2 million had not undergone a proper diagnostic procedure.

The obesity rates have been increasing rapidly in developed as well as developing economies across the globe. Factors such as unhealthy lifestyles and sedentary life are significant factors for the rise in the number of obese individuals. As per the data published by National Center for Health Statistics (NCHS), the prevalence of obesity is expected to be around 39.8%, affecting about 93.3 million US adults between the years 2015 to 2016. The incidence of obesity was significantly high among middle-aged adults (42.7%) compared to younger adults (35.7%). The increase in the number of obese people in the US has also led to rising healthcare expenditure.

Cardiovascular diseases (CVDs) include cerebrovascular disease, rheumatic heart disease, coronary heart disease, and other conditions. It is the most significant cause of morbidity and mortality worldwide. According to the European Cardiovascular Disease Statistics 2017, every year, cardiovascular diseases cause 3.9 million deaths and more than 1.8 million deaths in the European Union (EU). CVDs account for 45.0% of all deaths in Europe and 37.0% of deaths in the EU. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the US-which is around half of the US adult population-suffer from cardiovascular diseases.

Furthermore, there has been a rise in cancer incidence and mortality rates worldwide, making cancer the leading cause of death. According to the World Health Organization (WHO), in 2018, cancer was the cause of approximately 9.6 million deaths worldwide.

Moreover, according to the National Cancer Institute, in 2018, approximately 1,735,350 new cancer cases were diagnosed in the US. Similarly, in China, as per the data revealed by WHO, ~4.3 million new cancer cases were detected, and 2.9 million cancer deaths were recorded in 2018. Such an increase in the incidence of chronic and infectious diseases is expected to create a demand for immunoassay tests worldwide.


Product Insights

Based on product, the global immunohistochemistry market is segmented into antibodies, equipment, reagents, and kits. In 2020, the antibodies segment held the largest share of the market. However, the reagents segment is expected to register the highest CAGR in the market during 2021-2028. In immunohistochemistry, antibodies provide extremely high identification precision at the protein level, with better sensitivity and localization at the cellular or even subcellular scale. In the immunohistochemistry market, companies such as Thermo Fisher Scientific, Inc. and Bio-Rad Laboratories, Inc. provide antibodies for better analysis of the assays, which is expected to drive the market during the forecast period.


Application Insights

Based on application, the immunohistochemistry market is segmented into diagnostics and drug testing. The diagnostics segment held a larger market share in 2021. Moreover, the same segment is expected to hold a significant market share in the immunohistochemistry market due to the increasing use of IHC to diagnose various chronic diseases such as cancer, autoimmune diseases, infectious diseases, and nephrological diseases. The increase in the detection and diagnosis of different medical conditions worldwide is expected to drive the segment's growth.


End User Insights

Based on end user, the immunohistochemistry market is segmented into hospital & diagnostic laboratories, research institutes, and others. The hospital & diagnostic laboratories segment held the largest market share in 2021, and it is expected to continue dominating the market by 2028. The hospital & diagnostic laboratories segment is expected to hold a significant market share in the immunohistochemistry market due to the segment is also expected to grow at the fastest rate during the coming years owing to the hospitals are among the essential parts of the healthcare system of any country. Technological advancements aid hospitals in diagnosing and treating various disorders related to cardio, neuro, HIV, Hepatitis, oncology, and others.

A few major primary and secondary sources referred to while preparing the report on the global immunohistochemistry market are the Joint United Nations Programme on HIV/AIDS (UNAIDS), HIV and AIDS organization (AVERT), Center for Disease Control and Prevention (CDC), European Cardiovascular Disease Statistics, World Health Organization, US Census Bureau, European Union (EU), International Diabetes Federation (IDF), National Renal Foundation, Breast Cancer Organization, National Cancer Institute, Public Health Agency of Canada, American Society of Clinical Oncology, Central Intelligence Agency, Globocan, Neurological Alliance, International Trade Administration (ITA), Organisation for Economic Co-operation and Development (OECD), National Center for Biotechnology Information, Health Ministry of Japan, National Health Commission (NHC) of China, Indian Council for Medical Research, and The Cancer Association of South Africa (CANSA), among others.

Reasons to Buy


  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the immunohistochemistry market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Frequently Asked Questions about the Global Immunohistochemistry Market

What is the estimated value of the Global Immunohistochemistry Market?

The Global Immunohistochemistry Market was estimated to be valued at $2171.61 Million in 2021.

What is the growth rate of the Global Immunohistochemistry Market?

The growth rate of the Global Immunohistochemistry Market is 7.4%, with an estimated value of $3585.31 Million by 2028.

What is the forecasted size of the Global Immunohistochemistry Market?

The Global Immunohistochemistry Market is estimated to be worth $3585.31 Million by 2028.

Who are the key companies in the Global Immunohistochemistry Market?

Key companies in the Global Immunohistochemistry Market include F. Hoffmann, LA Roche AG, Merck KGaA, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Abcam Plc, Agilent Technologies, Bio SB and Rad Laboratories.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Immunohistochemistry Market - By Product
1.3.2 Global Immunohistochemistry Market - By Application
1.3.3 Global Immunohistochemistry Market - By End User
1.3.4 Global Immunohistochemistry Market - By Geography
2. Global Immunohistochemistry Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Immunohistochemistry Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Experts Opinion
5. Immunohistochemistry Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Chronic and Infectious Diseases
5.1.2 Increasing Geriatric Population
5.1.3 Increasing R&D Investments by Biotechnology & Biopharmaceutical Companies
5.2 Key Market Restraints
5.2.1 Limitations Associated with Immunohistochemistry
5.3 Key Market Opportunities
5.3.1 Development Opportunities in Emerging Countries
5.4 Future Trends
5.4.1 Increasing Acceptance of Automation in Immunohistochemistry
5.5 Impact Analysis
6. Immunohistochemistry Market - Global Analysis
6.1 Global Immunohistochemistry Market Revenue Forecast and Analysis
6.2 Global Immunohistochemistry Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Immunohistochemistry Market Revenue and Forecasts To 2028- by Product
7.1 Overview
7.2 Global Immunohistochemistry Market, By Product 2021 & 2028 (%)
7.3 Antibodies
7.3.1 Overview
7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.3.3 Primary Antibodies
7.3.3.1 Overview
7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.3.4 Secondary Antibodies
7.3.4.1 Overview
7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.4 Equipment Market
7.4.1 Overview
7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.4.3 Slide Staining Systems
7.4.3.1 Overview
7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.4.4 Tissue Microarrays
7.4.4.1 Overview
7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.4.5 Tissue Processing Systems
7.4.5.1 Overview
7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.4.6 Slide Scanners
7.4.6.1 Overview
7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.4.7 Other Equipment
7.4.7.1 Overview
7.4.7.2 Other Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5 Reagents Market
7.5.1 Overview
7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.3 Histological Stains
7.5.3.1 Overview
7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.4 Blocking Sera & Reagents Market
7.5.4.1 Overview
7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.5 Chromogenic Substrates Market
7.5.5.1 Overview
7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.6 Stabilizers
7.5.6.1 Overview
7.5.6.2 Global Stabilizers Market Revenue and Forecasts to 2028(US$ Mn)
7.5.7 Proteolytic Enzymes
7.5.7.1 Overview
7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.8 Organic Solvents
7.5.8.1 Overview
7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.9 Fixation Reagents
7.5.9.1 Overview
7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.10 Diluents
7.5.10.1 Overview
7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.6 Kits Market
7.6.1 Overview
7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
8. Immunohistochemistry Market Revenue and Forecasts To 2028 - Application
8.1 Overview
8.2 Global Immunohistochemistry Market Share by Application 2021 & 2028 (%)
8.3 Diagnostics
8.3.1 Overview
8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
8.3.3 Cancer
8.3.3.1 Overview
8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)
8.3.4 Infectious Diseases
8.3.4.1 Overview
8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.5 Autoimmune Diseases
8.3.5.1 Overview
8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.6 Diabetes Mellitus Market
8.3.6.1 Overview
8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)
8.3.7 Nephrological Diseases
8.3.7.1 Overview
8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.8 Others
8.3.8.1 Overview
8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Drug Testing
8.4.1 Overview
8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)
9. Global Immunohistochemistry Market Revenue and Forecasts To 2028- by End User
9.1 Overview
9.2 Global Immunohistochemistry Market, By End User 2021 & 2028 (%)
9.3 Hospital & Diagnostic Laboratories
9.3.1 Overview
9.3.2 Global Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
9.4 Research Institutes Market
9.4.1 Overview
9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
9.5 Others
9.5.1 Overview
9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10. Immunohistochemistry Market Revenue and Forecasts to 2028 - Geographical Analysis
10.1 North America Immunohistochemistry Market Revenue and Forecasts To 2028
10.1.1 North America Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.2 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.2.1 North America Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.1.2.2 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.2.3 North America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.3 North America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.1.3.1 North America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
10.1.4 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.5 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.1.5.1 US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.1.1 US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.1.2 US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.5.1.2.1 US Diagnostics Market Revenue and Forecasts To 2028, By Equipment (US$ Mn)
10.1.5.1.2.2 US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.5.1.2.3 US Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.1.5.1.3 US Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.5.1.3.1 US Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.5.1.4 US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.5.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.2.1 Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.2.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.5.2.2.1 Canada Diagnostics Market Revenue and Forecasts To 2028, By Equipment (US$ Mn)
10.1.5.2.2.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.5.2.2.3 Canada Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.1.5.2.3 Canada Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.5.2.3.1 Canada Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.5.2.4 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.5.3 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.3.1 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.3.2 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.5.3.2.1 Mexico Diagnostics Market Revenue and Forecasts To 2028, By Equipment (US$ Mn)
10.1.5.3.2.2 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.5.3.2.3 Mexico Antibodies Market Revenue and Forecasts To 2028, By Type (US$ Mn)
10.1.5.3.3 Mexico Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.5.3.3.1 Mexico Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.5.3.4 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.2 Europe: Immunohistochemistry Market Revenue and Forecasts to 2028
10.2.1 Europe: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.2 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.2.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.2.2.2 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.2.3 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.3 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.3.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.4 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.2.5 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.2.5.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.1.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.5.1.2.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.2.5.1.2.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.5.1.2.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.5.1.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.5.1.3.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.5.1.4 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.2.5.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.5.2.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.2.5.2.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.5.2.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.5.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.5.2.3.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.5.2.4 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.2.5.3 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.3.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.5.3.2.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.2.5.3.2.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.5.3.2.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.5.3.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.5.3.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.5.3.4 France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.2.5.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.4.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.4.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.5.4.2.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.2.5.4.2.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.5.4.2.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.5.4.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.5.4.3.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.5.4.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.2.5.5 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.5.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.5.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.5.5.2.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.2.5.5.2.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.5.5.2.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.5.5.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.5.5.3.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.5.5.4 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.2.5.6 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.6.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.6.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.5.6.2.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.2.5.6.2.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.5.6.2.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.5.6.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.5.6.3.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.5.6.4 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.3 Asia Pacific Immunohistochemistry Market Revenue and Forecasts To 2028
10.3.1 Overview
10.3.2 Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.3 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.3.1 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.3.2 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.3.3 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.4 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.4.1 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.3.5 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.3.6.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.1.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.1.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.6.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.6.1.2.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.6.1.2.3 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.6.1.3 Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.6.1.3.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.3.6.1.4 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.6.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.6.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.6.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.6.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.6.2.3.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.3.6.2.4 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.3 India Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.3.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.6.3.2.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.6.3.2.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.6.3.2.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.6.3.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.6.3.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.3.6.3.4 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.4.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.4.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.6.4.3.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.6.4.3.2 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.6.4.3.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.6.4.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.5 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.5.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.5.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.6.5.2.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.6.5.2.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.6.5.2.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.6.5.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.6.5.3.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.3.6.5.4 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.6 Rest of Asia Pacific: Immunohistochemistry Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Rest of Asia Pacific: Immunohistochemistry Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.6.6.2.1 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.6.6.2.2 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.6.6.2.3 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.6.6.3 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.6.6.3.1 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.3.6.6.4 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.4 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts To 2028
10.4.1 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.2 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.2.1 Middle East & Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.4.2.2 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.4.2.3 Middle East & Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.4.3 Middle East & Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.4.3.1 Middle East & Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
10.4.4 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.4.5 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.4.5.1 UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.1.1 UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.1.2 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.5.1.2.1 UAE Diagnostics Market Revenue and Forecasts To 2028, By Equipment (US$ Mn)
10.4.5.1.2.2 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.4.5.1.2.3 UAE Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.4.5.1.3 UAE Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.4.5.1.3.1 UAE Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.4.5.1.4 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.4.5.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.2.1 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.2.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.5.2.2.1 Saudi Arabia Diagnostics Market Revenue and Forecasts To 2028, By Equipment (US$ Mn)
10.4.5.2.2.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.4.5.2.2.3 Saudi Arabia Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.4.5.2.3 Saudi Arabia Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.4.5.2.3.1 Saudi Arabia Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.4.5.2.4 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.4.5.3 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.3.1 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.3.2 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.5.3.2.1 South Africa Diagnostics Market Revenue and Forecasts To 2028, By Equipment (US$ Mn)
10.4.5.3.2.2 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.4.5.3.2.3 South Africa Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.4.5.3.3 South Africa Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.4.5.3.3.1 South Africa Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.4.5.3.4 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.4.5.4 Rest of Middle East and Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.4.1 Rest of Middle East and Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.4.2 Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.5.4.2.1 Rest of Middle East & Africa Diagnostics Market Revenue and Forecasts To 2028, By Equipment (US$ Mn)
10.4.5.4.2.2 Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.4.5.4.2.3 Rest of Middle East & Africa Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.4.5.4.3 Rest of Middle East & Africa Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.4.5.4.3.1 Rest of Middle East & Africa Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.4.5.4.4 Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.5 South And Central America Immunohistochemistry Market Revenue and Forecasts To 2028
10.5.1 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.2 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.5.2.1 South and Central America Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.5.2.2 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.5.2.3 South and Central America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.5.3 South and Central America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.5.3.1 South and Central America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
10.5.4 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.5.5 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.5.5.1 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.1.1 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.1.2 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.5.5.1.2.1 Argentina Diagnostics Market Revenue and Forecasts To 2028, By Equipment (US$ Mn)
10.5.5.1.2.2 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.5.5.1.2.3 Argentina Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.5.5.1.3 Argentina Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.5.5.1.3.1 Argentina Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.5.5.1.4 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.5.5.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.2.1 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.2.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.5.5.2.2.1 Brazil Diagnostics Market Revenue and Forecasts To 2028, By Equipment (US$ Mn)
10.5.5.2.2.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.5.5.2.2.3 Brazil Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.5.5.2.3 Brazil Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.5.5.2.3.1 Brazil Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.5.5.2.4 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.5.5.3 Rest of South and Central America: Immunohistochemistry Market- Revenue and Forecast to 2028 (USD Mn)
10.5.5.3.1 Rest of South and Central America: Immunohistochemistry Market- Revenue and Forecast to 2028 (USD Mn)
10.5.5.3.2 Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.5.5.3.2.1 Rest of South & Central America Diagnostics Market Revenue and Forecasts To 2028, By Equipment (US$ Mn)
10.5.5.3.2.2 Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.5.5.3.2.3 Rest of South & Central America Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.5.5.3.3 Rest of South & Central America Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.5.5.3.3.1 Rest of South & Central America Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.5.5.3.4 Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
11. Impact Of COVID-19 Pandemic on Immunohistochemistry Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Immunohistochemistry Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Company Profiles
13.1 Cell Signaling Technology, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MERCK KGaA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 PerkinElmer Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 THERMO FISHER SCIENTIFIC INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Abcam plc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Agilent Technologies, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BIO-RAD LABORATORIES INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Danaher
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Bio SB
List of Tables
Table 1. R&D Investments by Major Biopharmaceutical Companies
Table 2. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 3. North America Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 4. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 5. North America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 6. North America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 7. North America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 8. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 9. US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 10. US Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 11. US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 12. US Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 13. US Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 14. US Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 15. US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 16. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 17. Canada Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 18. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 19. Canada Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 20. Canada Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 21. Canada Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 22. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 23. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 24. Mexico Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 25. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 26. Mexico Antibodies Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 27. Mexico Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 28. Mexico Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 29. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 30. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn).
Table 31. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn).
Table 32. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn).
Table 33. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn).
Table 34. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 35. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 36. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 37. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 38. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 39. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 40. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 41. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 42. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 43. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)
Table 44. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 45. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 46. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 47. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 48. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 49. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 50. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)
Table 51. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 52. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 53. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 54. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 55. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 56. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 57. France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 58. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 59. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 60. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 61. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 62. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 63. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 64. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 65. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 66. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 67. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 68. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 69. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Application (USD Million)
Table 70. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Diagnostics (USD Million)
Table 71. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by End User (USD Million)
Table 72. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 73. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 74. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 75. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 76. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 77. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 78. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 79. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 80. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 81. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 82. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 83. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 84. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 85. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 86. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 87. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 88. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 89. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 90. Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 91. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 92. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 93. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 94. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 95. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 96. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 97. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 98. China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 99. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 100. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 101. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 102. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 103. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 104. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 105. India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 106. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 107. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 108. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 109. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 110. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 111. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 112. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 113. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 114. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 115. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 116. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 117. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 118. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 119. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 120. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 121. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 122. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 123. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 124. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 125. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 126. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 127. Middle East & Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 128. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 129. Middle East & Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 130. Middle East & Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 131. Middle East & Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 132. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 133. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 134. UAE Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 135. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 136. UAE Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 137. UAE Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 138. UAE Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 139. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 140. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 141. Saudi Arabia Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 142. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 143. Saudi Arabia Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 144. Saudi Arabia Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 145. Saudi Arabia Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 146. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 147. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 148. South Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 149. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 150. South Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 151. South Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 152. South Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 153. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 154. Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 155. Rest of Middle East & Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 156. Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 157. Rest of Middle East & Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 158. Rest of Middle East & Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 159. Rest of Middle East & Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 160. Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 161. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 162. South and Central America Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 163. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 164. South and Central America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 165. South and Central America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 166. South and Central America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 167. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 168. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 169. Argentina Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 170. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 171. Argentina Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 172. Argentina Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 173. Argentina Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 174. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 175. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 176. Brazil Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 177. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 178. Brazil Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 179. Brazil Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 180. Brazil Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 181. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 182. Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 183. Rest of South & Central America Diagnostics Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 184. Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 185. Rest of South & Central America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 186. Rest of South & Central America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 187. Rest of South & Central America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 188. Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 189. Organic Developments Done By Companies
Table 190. Inorganic developments done by Companies
Table 191. Glossary of Terms, Immunohistochemistry Market
List of Figures
Figure 1. Immunohistochemistry Market Segmentation
Figure 2. Immunohistochemistry Market Segmentation, By Region
Figure 3. Global Immunohistochemistry Market Overview
Figure 4. Antibodies Segment Held the Largest Share of the Product Segment in Immunohistochemistry Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Immunohistochemistry Market, by Geography (US$ Million)
Figure 7. Global Immunohistochemistry Market - Leading Country Markets (US$ Million)
Figure 8. Global Immunohistochemistry Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Impact Analysis of Drivers and Restraints Pertaining to Immunohistochemistry Market
Figure 15. Global Immunohistochemistry Market - Revenue Forecast and Analysis - 2020- 2028
Figure 16. Global Immunohistochemistry Market - By Geography Forecast and Analysis - 2021- 2028
Figure 17. Market Positioning of Key Players in Global Immunohistochemistry Market
Figure 18. Global Immunohistochemistry Market, by Product 2021 & 2028 (%)
Figure 19. Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 20. Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 21. Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 22. Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 23. Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 24. Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 25. Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 26. Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 27. Other Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 28. Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 29. Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 30. Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 31. Global Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 32. Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 33. Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 34. Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 35. Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 36. Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 37. Kits: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 38. Global Immunohistochemistry Market Share by Application 2021 & 2028 (%)
Figure 39. Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 40. Cancer Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 41. Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 42. Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 43. Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 44. Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 45. Others Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 46. Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 47. Global Immunohistochemistry Market, by End User 2021 & 2028 (%)
Figure 48. Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 49. Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 50. Others: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 51. North America Immunohistochemistry Market Revenue Overview, by Country (2021) (US$ Mn)
Figure 52. North America Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 53. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 54. US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 55. Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 56. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 57. Europe: Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 58. Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 59. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 60. UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 61. Germany Immunohistochemistry Products Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 62. France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 63. Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 64. Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 65. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 66. Asia Pacific Immunohistochemistry Market Overview, by Country (2018)
Figure 67. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 68. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 69. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 70. China: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 71. India: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 72. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 73. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 74. Rest of Asia Pacific: Immunohistochemistry Market - Revenue and Forecast to 2028 (USD Million)
Figure 75. Middle East & Africa Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 76. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 77. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 78. UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 79. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 80. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 81. Rest of Middle East and Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 82. South and Central America Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 83. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 84. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 85. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 86. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 87. Rest of South and Central America: Immunohistochemistry Market- Revenue and Forecast to 2028 (USD Mn)
Figure 88. Impact of COVID-19 Pandemic in North American Country Markets
Figure 89. Impact of COVID-19 Pandemic in European Country Markets
Figure 90. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 91. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 92. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 93. Growth Strategies done by the companies in the Market (%)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • F. Hoffmann-LA Roche AG
  • Merck KGaA
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.
  • Abcam Plc
  • Agilent Technologies
  • Bio SB
  • Bio-Rad Laboratories
  • Cell Signaling Technology, Inc.
  • Danaher Corporation